Giuseppe Murdaca
Overview
Explore the profile of Giuseppe Murdaca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
2192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tonello S, DOnghia D, Di Ruscio A, Mora S, Vincenzi F, Caria G, et al.
Pharmaceuticals (Basel)
. 2025 Feb;
18(2).
PMID: 40006072
Pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) are severe complications of patients with systemic sclerosis (SSc). Currently, there are a few tests for early identification of these conditions,...
2.
Cacciapaglia F, De Angelis R, Ferri C, Bajocchi G, Bellando-Randone S, Bruni C, et al.
J Rheumatol
. 2025 Jan;
PMID: 39814435
Objective: Bosentan (BOS) is approved for treating pulmonary arterial hypertension (PAH) and preventing digital ulcers (DU) in systemic sclerosis (SSc). Our study aimed to evaluate whether BOS prescribed for DU...
3.
Cabanillas B, Murdaca G, Guemari A, Torres M, Azkur A, Aksoy E, et al.
Allergy
. 2024 Nov;
79(12):3285-3309.
PMID: 39495103
As the world still vividly recalls the previous monkeypox (mpox) outbreak that impacted over 120 countries worldwide with more than 99,000 cases in 2022, we are now facing a second...
4.
Caserta S, Cancemi G, Murdaca G, Stagno F, Di Gioacchino M, Gangemi S, et al.
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335619
In recent years, cancer management has benefitted from new effective treatments, including immunotherapy. While these therapies improve cancer survival rates, they can alter immune responses and cause long-term side effects,...
5.
Casabella A, Paladin F, Bighin C, Ottaviani S, Marelli C, Ponzano M, et al.
Intern Emerg Med
. 2024 Aug;
19(8):2193-2199.
PMID: 39095675
The raising number of older patients who are diagnosed with breast cancer represents a significant medical and societal challenge. Aromatase inhibitors (AI), which are commonly utilized to treat this condition...
6.
Murdaca G, Tagliafico L, Page E, Paladin F, Gangemi S
Biomedicines
. 2024 May;
12(5).
PMID: 38790985
The synergic role of vitamin D and the intestinal microbiota in the regulation of the immune system has been thoroughly described in the literature. Vitamin D deficiency and intestinal dysbiosis...
7.
Bruschi M, Angeletti A, Prunotto M, Meroni P, Ghiggeri G, Moroni G, et al.
Autoimmun Rev
. 2024 Mar;
23(5):103535.
PMID: 38552995
Deposition of autoantibodies in glomeruli is a key factor in the development of lupus nephritis (LN). For a long time, anti-dsDNA and anti-C1q antibodies were thought to be the main...
8.
Allegra A, Murdaca G, Mirabile G, Gangemi S
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540127
Lipid metabolism is intrinsically linked to tumorigenesis. And one of the most important characteristics of cancer is the modification of lipid metabolism and its correlation with oncogenic signaling pathways within...
9.
Murdaca G, Gangemi S
Biomedicines
. 2024 Feb;
12(2).
PMID: 38397926
Vitamin D (VD) is a fat-soluble vitamin considered essential for human health, and its levels are associated with the function and composition of the intestinal microbiome [...].
10.
Riccieri V, Pellegrino G, Cipolletta E, Giuggioli D, Bajocchi G, Bellando-Randone S, et al.
J Scleroderma Relat Disord
. 2024 Feb;
9(1):38-49.
PMID: 38333531
Background: Intravenous iloprost has been widely used for the treatment of systemic sclerosis peripheral vasculopathy. No agreement has been found on the regimen and the dosage of intravenous iloprost in...